Viking Therapeutics Inc. (VKTX)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 1 |
Ownership rank: | 667 |
% of all portfolios: | 0.002% |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
Q3  2024 | |||||
≡ | Viking Global Investors | Reduce 46.70% | 632,524 | 0.15 | |
Q2  2024 | |||||
≡ | Viking Global Investors | Add 23.70% | 259,510 | 0.05 | |
Q1  2024 | |||||
≡ | Viking Global Investors | Reduce 78.72% | 4,050,172 | 1.22 | |
Q4  2023 | |||||
≡ | Viking Global Investors | Add 12.50% | 571,796 | 0.04 | |
Q3  2023 | |||||
≡ | Viking Global Investors | Add 29.03% | 1,028,810 | 0.05 | |
Q2  2023 | |||||
≡ | Viking Global Investors | Add 81.30% | 1,589,443 | 0.11 | |
Q1  2023 | |||||
≡ | Viking Global Investors | Buy | 1,955,063 | 0.15 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.